Emil D. Kakkis, President & CEO: Ultragenyx Pharmaceutical RARE Sell · Filed 23/10/23

Trade details

Type: Insider sale
Amount: $1,604,032.56
Shares · price: 47,853 sh · $33.52 a share
Held after: 599,743 sh
Stock: Ultragenyx Pharmaceutical RARE
Person: Emil D. KakkisPresident & CEO
Trade date: 23/10/19
Filed: 23/10/23
Days to filing: 4 days

Sold 7.4% of holdings

Share of holding sold: 7.4%

Ultragenyx Pharmaceutical trades, last 26 weeks

What else happened in Ultragenyx Pharmaceutical around then

Filed or reported within 30 days of the trade day · 23/09/19~23/11/18

Emil D. Kakkis's recent trades

Emil D. KakkisPresident & CEO
SellUltragenyx Pharmaceutical
Sell
Ultragenyx Pharmaceutical
RARE
$1.2M
54,404 sh
$1.2M
Filed 03/03
Traded 03/02
Emil D. KakkisPresident & CEO
Sell10b5-1 planUltragenyx Pharmaceutical
Sell10b5-1 plan
Ultragenyx Pharmaceutical
RARE
$3.1M
73,434 sh
$3.1M
Filed 25/03/04
Traded 25/03/03
Emil D. KakkisPresident & CEO
Sell10b5-1 planUltragenyx Pharmaceutical
Sell10b5-1 plan
Ultragenyx Pharmaceutical
RARE
$1.1M
25,000 sh
$1.1M
Filed 25/03/04
Traded 25/02/28
Emil D. KakkisOfficer
Planned sale10b5-1 planUltragenyx Pharmaceutical
Planned sale10b5-1 plan
Ultragenyx Pharmaceutical
RARE
$1.1M
25,000 sh
$1.1M
Filed 25/02/28
Traded 25/02/28
Emil D. KakkisPresident & CEO
Sell10b5-1 planUltragenyx Pharmaceutical
Sell10b5-1 plan
Ultragenyx Pharmaceutical
RARE
$495.2K
11,727 sh
$495.2K
Filed 24/12/31
Traded 24/12/30